Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Genius Sports $150 million follow-on offering
The shares are listed on the NYSE
GeoPark $550 million notes offering and concurrent cash tender offer
We advised GeoPark on its high-yield notes offering and concurrent tender offer
Toronto-Dominion Bank $2.5 billion notes offering
The investment-grade debt offering consists of three tranches
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
JPMorgan Chase €2 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Kioxia Holdings ¥120.4 billion IPO
The shares are listed on the Tokyo Stock Exchange
Bacardi $1 billion notes offering
The investment-grade notes are due 2030 and 2035
Sanrio ¥135.1 billion secondary offering
The shares are listed on the Tokyo Stock Exchange
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Province of Saskatchewan $1 billion global bond offering
The investment-grade debt is due 2030